Urotensin-II, oxidative stress, and inflammation increase in hypertensive and resistant hypertensive patients.

Guler E. M., Gokce M., Bacaksiz A., Kocyigit A.

Clinical and experimental hypertension (New York, N.Y. : 1993), vol.43, pp.211-216, 2021 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 43
  • Publication Date: 2021
  • Doi Number: 10.1080/10641963.2020.1847128
  • Journal Name: Clinical and experimental hypertension (New York, N.Y. : 1993)
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus, Academic Search Premier, BIOSIS, CAB Abstracts, EMBASE, Food Science & Technology Abstracts, MEDLINE, Veterinary Science Database
  • Page Numbers: pp.211-216
  • Keywords: Resistant hypertension, urotensin-II, oxidative stress, inflammation, C-REACTIVE PROTEIN, THIOL/DISULPHIDE HOMEOSTASIS, MODIFICATION HYPOTHESIS, INCREASED EXPRESSION, SMOOTH-MUSCLE, ATHEROSCLEROSIS
  • Bezmialem Vakıf University Affiliated: Yes

Abstract

Objective: Hypertension is a multi-factorial process prevalent in developed as well as in developing countries. Urotensin-II, different antioxidants, free radicals, and inflammatory biomarkers play an essential role in the cardiovascular system. The aim of this study is to investigate Urotensin-II, oxidative stress, and inflammation markers in normotensive, hypertensive, and resistant hypertensive patients.